Drug Anticounterfeiting by RFID

08 October 2007 | by Dr Peter Harrop
It was sad that the Food and Drug Administration backed off from urgently pushing through standards and rapid adoption of RFID at item level on drugs, after its earlier firm lead in 2005-6. However, its recommendation remains but with industry left to set the pace.
You are not logged in. For existing users, please login to learn more about this premium content. For new users, please register with idtechex.com or use the links below for more details about premium content from IDTechEx.

Subscription Benefits


A subscription from IDTechEx allows you to access our full body of research content on emerging technologies, including market, technology and company data, alongside direct engagement with our expert analysts.
Subscription content includes:
  • Market research reports
  • Forecasts
  • Premium articles
  • Company profiles
  • Industry digests
  • Webinars
  • Innovation maps
  • Event summaries and write-ups